Literature DB >> 25263829

Preterm infants who later require duct ligation show different vital signs and pH in early postnatal life.

Manuel Steiner1, Ulrike Salzer-Muhar, Vanessa Swoboda, Lukas Unterasinger, Sigrid Baumgartner, Thomas Waldhoer, Michaela Langgartner, Katrin Klebermass-Schrehof, Angelika Berger.   

Abstract

AIM: The study investigated early postnatal vital signs in very low birthweight (VLBW) infants who later developed patent ductus arteriosus (PDA). We hypothesised that the early postnatal course of vital signs and blood gas variables might differ between infants whose PDA closed spontaneously, those who responded to ibuprofen and those who later required PDA ligation.
METHODS: We analysed computerised records of VLBW infants born <28 weeks of gestational age, including vital signs, arterial pH values and echocardiographic data from the first postnatal days.
RESULTS: In total, 104 infants were included in the study. In the group of infants born <26 weeks of gestational age and requiring ibuprofen for PDA (n = 34), 12 infants ultimately required surgical ligation. Infants requiring ligation showed significantly lower oxygen saturation (p = 0.019), mean blood pressure (p = 0.034) and higher heart rate fluctuation ranges (p = 0.040) in the first five postnatal days than those who responded to ibuprofen. In multivariable logistic regression analysis, lower pH values in the first 48 h predicted the subsequent requirement for ligation independent of gestational age (p = 0.004).
CONCLUSION: Patients <26 weeks of gestational age requiring PDA ligation showed significant differences in the course of vital signs and pH during the first days of life. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Ligation; Patent ductus; Preterm; Vital signs

Mesh:

Year:  2014        PMID: 25263829     DOI: 10.1111/apa.12814

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

Review 1.  Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.

Authors:  Yang Hu; Hongfang Jin; Yi Jiang; Junbao Du
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

2.  Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus.

Authors:  Janardhan Mydam; Alok Rastogi; Zahra J Naheed
Journal:  Ital J Pediatr       Date:  2019-08-22       Impact factor: 2.638

Review 3.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.